Home LiteratureArticle Details
PMID: 5443406 Published · ppublish English Journal Article

Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs.

British medical journal ·Vol. 2 ·No. 5703 ·1970-04-25 ·Pages 203-9

Inman WH, Vessey MP, Westerholm B, Engelund A

Abstract

Reports of thromboembolism following the use of oral contraceptives received by drug safety committees in the United Kingdom, Sweden, and Denmark have been analysed to investigate possible differences in the risks associated with the various preparations. For this purpose the numbers of reports of thromboembolism attributed to each product were compared with the distribution that would have been expected from market research estimates of sales, assuming that all products carried the same risk.A positive correlation was found between the dose of oestrogen and the risk of pulmonary embolism, deep vein thrombosis, cerebral thrombosis, and coronary thrombosis in the United Kingdom. A similar association was found for venous thrombosis and pulmonary embolism in Sweden and Denmark. No significant differences could be detected between sequential and combined preparations containing the same doses of oestrogen, nor between the two oestrogens, ethinyloestradiol and mestranol.Certain discrepancies in the data suggest that the dose of oestrogen may not be the only factor related to the risk of thromboembolism; thus there was a significant deficit of reports associated with the combination of mestranol 100 mug. with norethynodrel 2.5 mg. and a significant excess of reports associated with the combination of ethinyloestradiol 50 mug. with megestrol acetate 4 mg. An excess of reports also occurred with other combined preparations containing megestrol acetate.The data obtained in earlier epidemiological studies were re-examined and, though no trend was obvious in any one of them, the combined results showed an excess of cases of thromboembolism at the highest dose of oestrogen.The finding of a positive correlation between the dose of oestrogen and the risk of coronary thrombosis is of special interest since previous studies have failed to provide clear evidence of a relationship between oral contraceptives and this condition.

MeSH Terms
Contraceptives, Oral/adverse effects Coronary Disease/chemically induced Denmark Estrogens/administration & dosage,adverse effects Ethinyl Estradiol/adverse effects Female Humans Intracranial Embolism and Thrombosis/chemically induced Megestrol/adverse effects Mestranol/adverse effects Norethynodrel/adverse effects Progestins/administration & dosage Pulmonary Embolism/chemically induced Sweden Thromboembolism/chemically induced,epidemiology Thrombophlebitis/chemically induced United Kingdom
Chemicals
Contraceptives, Oral Estrogens Progestins Ethinyl Estradiol Norethynodrel Mestranol Megestrol
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Inman W H
Vessey M P
Westerholm B
Engelund A
References (8)
8 references, click to expand
  1. Puerperal thromboembolism and suppression of lactation.
    Lancet. 1967 Aug 5;2(7510):287-9 PMID: 4165919
  2. Influence of reduction of serum lipids on prognosis of coronary heart-disease. A five-year study using oestrogen.
    Lancet. 1961 Sep 2;2(7201):499-505 PMID: 13730811
  3. Thromboembolism and oral contraceptives: an epidemiologic case-control study.
    Am J Epidemiol. 1969 Nov;90(5):365-80 PMID: 5395236
  4. Venous effects of oral contraceptives.
    Br Med J. 1969 Oct 11;4(5675):73-7 PMID: 5823051
  5. Puerperal thromboembolism.
    Br Med J. 1968 Nov 16;4(5628):452 PMID: 5687616
  6. Puerperal thromboembolism in relation to the inhibition of lactation by oestrogen therapy.
    Br Med J. 1968 Oct 5;4(5622):19-25 PMID: 5677208
  7. Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age.
    Br Med J. 1968 Apr 27;2(5599):193-9 PMID: 5653024
  8. Thromboembolism and oestrogen therapy.
    Lancet. 1967 Sep 9;2(7515):560 PMID: 4166904
Article Info
Journal
British medical journal
Abbr.
Br Med J
ISSN
0007-1447
Published
1970-04-25
Pages
203-9
Language
English
Region
England
NLM ID
0372673
PMCID
PMC1700093
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com